Taiwan clears VUNO’s AI fundus evaluation instrument
South Korean agency VUNO has gained the approval of Taiwan’s Meals and Drug Administration to market its AI fundus evaluation software program.
VUNO Med-Fundus AI analyses photographs of the fundus to shortly detect areas of lesions indicative of retinal ailments, together with diabetic retinopathy, macular illness and glaucoma.
This newest certification follows Taiwan FDA’s clearance for its different AI merchandise, VUNO-Med Chest X-ray and VUNO-Med Bone Age. Simply two months in the past, VUNO obtained Singapore’s clearance for VUNO Med-Fundus AI.
Research validates AIRS Medical’s AI answer for denoising 3D MR photographs
AIRS Medical, a medical AI startup from South Korea, has not too long ago proved in a examine the aptitude of its AI-powered MRI reconstruction answer, SwiftMR, to denoise and tremendously enhance the standard of 3D MR photographs.
Primarily based on its findings, a deep neural network-based noise discount and picture high quality enchancment instrument outperformed the traditional magnetisation-prepared fast gradient-echo (MP-RAGE) sequence in enhancing MR picture high quality.
“We’re more than happy that now we have proved SwiftMR contributes to not solely decreasing time but in addition [helping] make photographs nice, finally [helping] radiologists learn photographs with confidence,” mentioned AIRS Medical CEO Dr Hyeseong Lee.
Qure.ai packages options utilizing NVIDIA’s MONAI equipment
Indian well being expertise startup Qure.ai is likely one of the early adopters of NVIDIA’s newest open-source framework for deploying AI medical imaging purposes.
The MONAI Software Packages (MAP) simplify the method of deploying an AI mannequin in an present healthcare ecosystem.
Qure.ai is now packaging its AI options for deployment utilizing MAPs, accelerating its scientific affect, in response to NVIDIA.
UK-based Cambridge Cognition brings mind well being options to China
London-listed Cambridge Cognition, a supplier of cognitive evaluation take a look at options, has entered into a brand new partnership to deliver its digital well being choices to China.
The corporate not too long ago signed a 10-year unique licensing deal and strategic partnership with Luca Healthcare, a neighborhood developer of digital well being evaluation instruments.
Luca might be making Cambridge Cognition’s CANTAB suite of digital mind well being exams out there in China through its LucaPlex platform.
“China has over 265 million folks aged 60 years and above, of which 40 million folks have gentle cognitive impairment and 15 million folks with a type of dementia. With neurodegenerative ailments, early analysis is the important thing to managing illness development. We’ll leverage Cambridge Cognition’s analysis, scientific know-how, and digital expertise to make out there superior cognitive evaluation instruments for the scientific trials market and the healthcare market in China,” mentioned Luca CEO Echo Chen.
#Roundup #Taiwan #approves #VUNOs #fundus #instrument #briefs
- Donate withBitcoin
- Donate withDogecoin
- Donate withLitecoin
- Donate withTether
- Donate withBinance coin
- Donate withTron
- Donate withBitcoin cash
- Donate withDash